# Multi-cancer early detection (MCED)

Reagents & kits — Multi-cancer early detection (MCED) screens asymptomatic, average-risk individuals from a single blood draw for molecular signals shared across dozens of cancer types — a population-screening scenario distinct from companion-therapy diagnostics. The technology base is circulating-DNA, methylation-pattern and protein-signal analysis. Sample-prep and signal-analysis reagents are procured.

Source: https://en.bioecon.ru/market/reagents-kits/multi-cancer-early-detection/